Presentation

CYP2C19-2 and 17 Alleles Have Significant Impact on Platelet Response and Bleeding Risk in Patients Treated with Prasugrel After ACS

Presenter: Thomas Cuisset

December 16, 2012

REGISTER for free or LOG IN to view this content

CYP2C19-2 and 17 Alleles Have Significant Impact on Platelet Response and Bleeding Risk in Patients Treated with Prasugrel After ACS

Coronary

Factoid

Up Next

Presentation

Safety and Efficacy of High- vs. Low-Dose Aspirin After Primary PCI in STEMI

Presenter: J. Yu

December 17, 2012

More slides +

Presentation

Association of Clopidogrel Pretreatment with Mortality, CV Events, and Major Bleeding After PCI

Presenter: A. Bellemain-Appaix

December 17, 2012

Presentation

The Prevalence and Outcomes of Transradial PCI for STEMI: NCDR CathPCI Registry, 2007-2011

Presenter: D.V. Baklanov

December 18, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.